Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00391362PMID 2606933PMCID PMC12211584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Head and neck cancer: chemotherapy concepts.

  1988cited by this paper
• Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

  1987cited by this paper
• Cisplatin and 5‐fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

  1987cited by this paper
• Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.

  1986cited by this paper
• A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

  1985cited by this paper
• Improved complete response rate and survival in advanced head and neck cancer after three‐course induction therapy with 120‐hour 5‐FU infusion and cisplatin

  1985cited by this paper
• Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.

  1985cited by this paper
• A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) infusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

  1985cited by this paper
• A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.

  1985cited by this paper
• Chemotherapy strategies in squamous cell carcinoma of the head and neck.

  1984cited by this paper
• Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

  1984cited by this paper
• Chemotherapy in head and neck cancer.

  1983cited by this paper
• A randomized trial of the combination of cis‐platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck

  1983cited by this paper
• Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5‐fluorouracil, methotrexate, and vitamin A

  1980cited by this paper
• Combination chemotherapy with cis‐diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase II

  1980cited by this paper
• Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck

  1979cited by this paper
• Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis‐diamminedichloroplatinum II in an effective outpatient schedule

  1979cited by this paper
• Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

  1979cited by this paper
• An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts

  1977cited by this paper

• High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck

  2005cites this paper
• Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.

  2002cites this paper
• Vinorelbine, cisplatin, and 5‐fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck

  1997cites this paper
• Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study.

  1996cites this paper
• Vinorelbine Plus Cisplatin in Recurrent or Previously Untreated Unresectable Squamous Cell Carcinoma of the Head and Neck

  1995cites this paper
• Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial.

  1995cites this paper
• A short-term infusion regimen of Cisplatin, 5-Fluorouracil and L-folinic Acid in advanced head and neck-carcinoma.

  1994cites this paper
• A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma.

  1993cites this paper
• Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.

  1993cites this paper
• Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer

  1992cites this paper
• Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma.

  1992cites this paper
• Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease.

  1992cites this paper
• Cisplatin plus continuous infusion of 5‐fluorouracil for 5 days effective for patients with advanced gastric cancer

  1991cites this paper
• The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.

  1990cites this paper